CRT 2024

CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL SCIENCE: A Blood Biomarker-Based Diagnosis of Reperfused Hemorrhagic ST-Elevation Myocardial Infarction Predicts Acute Outcomes

Interviewer(s)

• 

  David F. Kong, MD, AM, DMT

  Associate Professor of Medicine
  Duke University
  Durham, North Carolina, United States

  Disclosure(s): No financial relationships to disclose

Interviewee(s)

• 

  Ankur Kalra, MD

  Interventional Cardiologist
  Franciscan Health, United States

  Disclosure information not submitted.